Cargando…
Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning
BACKGROUND: The human ATP binding cassette transporters Breast Cancer Resistance Protein (BCRP) and Multidrug Resistance Protein 1 (P-gp) are co-expressed in many tissues and barriers, especially at the blood–brain barrier and at the hepatocyte canalicular membrane. Understanding their interplay in...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743411/ https://www.ncbi.nlm.nih.gov/pubmed/26855674 http://dx.doi.org/10.1186/s13321-016-0121-y |
_version_ | 1782414362825195520 |
---|---|
author | Montanari, Floriane Zdrazil, Barbara Digles, Daniela Ecker, Gerhard F. |
author_facet | Montanari, Floriane Zdrazil, Barbara Digles, Daniela Ecker, Gerhard F. |
author_sort | Montanari, Floriane |
collection | PubMed |
description | BACKGROUND: The human ATP binding cassette transporters Breast Cancer Resistance Protein (BCRP) and Multidrug Resistance Protein 1 (P-gp) are co-expressed in many tissues and barriers, especially at the blood–brain barrier and at the hepatocyte canalicular membrane. Understanding their interplay in affecting the pharmacokinetics of drugs is of prime interest. In silico tools to predict inhibition and substrate profiles towards BCRP and P-gp might serve as early filters in the drug discovery and development process. However, to build such models, pharmacological data must be collected for both targets, which is a tedious task, often involving manual and poorly reproducible steps. RESULTS: Compounds with inhibitory activity measured against BCRP and/or P-gp were retrieved by combining Open Data and manually curated data from literature using a KNIME workflow. After determination of compound overlap, machine learning approaches were used to establish multi-label classification models for BCRP/P-gp. Different ways of addressing multi-label problems are explored and compared: label-powerset, binary relevance and classifiers chain. Label-powerset revealed important molecular features for selective or polyspecific inhibitory activity. In our dataset, only two descriptors (the numbers of hydrophobic and aromatic atoms) were sufficient to separate selective BCRP inhibitors from selective P-gp inhibitors. Also, dual inhibitors share properties with both groups of selective inhibitors. Binary relevance and classifiers chain allow improving the predictivity of the models. CONCLUSIONS: The KNIME workflow proved a useful tool to merge data from diverse sources. It could be used for building multi-label datasets of any set of pharmacological targets for which there is data available either in the open domain or in-house. By applying various multi-label learning algorithms, important molecular features driving transporter selectivity could be retrieved. Finally, using the dataset with missing annotations, predictive models can be derived in cases where no accurate dense dataset is available (not enough data overlap or no well balanced class distribution). [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13321-016-0121-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4743411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-47434112016-02-06 Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning Montanari, Floriane Zdrazil, Barbara Digles, Daniela Ecker, Gerhard F. J Cheminform Research Article BACKGROUND: The human ATP binding cassette transporters Breast Cancer Resistance Protein (BCRP) and Multidrug Resistance Protein 1 (P-gp) are co-expressed in many tissues and barriers, especially at the blood–brain barrier and at the hepatocyte canalicular membrane. Understanding their interplay in affecting the pharmacokinetics of drugs is of prime interest. In silico tools to predict inhibition and substrate profiles towards BCRP and P-gp might serve as early filters in the drug discovery and development process. However, to build such models, pharmacological data must be collected for both targets, which is a tedious task, often involving manual and poorly reproducible steps. RESULTS: Compounds with inhibitory activity measured against BCRP and/or P-gp were retrieved by combining Open Data and manually curated data from literature using a KNIME workflow. After determination of compound overlap, machine learning approaches were used to establish multi-label classification models for BCRP/P-gp. Different ways of addressing multi-label problems are explored and compared: label-powerset, binary relevance and classifiers chain. Label-powerset revealed important molecular features for selective or polyspecific inhibitory activity. In our dataset, only two descriptors (the numbers of hydrophobic and aromatic atoms) were sufficient to separate selective BCRP inhibitors from selective P-gp inhibitors. Also, dual inhibitors share properties with both groups of selective inhibitors. Binary relevance and classifiers chain allow improving the predictivity of the models. CONCLUSIONS: The KNIME workflow proved a useful tool to merge data from diverse sources. It could be used for building multi-label datasets of any set of pharmacological targets for which there is data available either in the open domain or in-house. By applying various multi-label learning algorithms, important molecular features driving transporter selectivity could be retrieved. Finally, using the dataset with missing annotations, predictive models can be derived in cases where no accurate dense dataset is available (not enough data overlap or no well balanced class distribution). [Figure: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13321-016-0121-y) contains supplementary material, which is available to authorized users. Springer International Publishing 2016-02-04 /pmc/articles/PMC4743411/ /pubmed/26855674 http://dx.doi.org/10.1186/s13321-016-0121-y Text en © Montanari et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Montanari, Floriane Zdrazil, Barbara Digles, Daniela Ecker, Gerhard F. Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning |
title | Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning |
title_full | Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning |
title_fullStr | Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning |
title_full_unstemmed | Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning |
title_short | Selectivity profiling of BCRP versus P-gp inhibition: from automated collection of polypharmacology data to multi-label learning |
title_sort | selectivity profiling of bcrp versus p-gp inhibition: from automated collection of polypharmacology data to multi-label learning |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743411/ https://www.ncbi.nlm.nih.gov/pubmed/26855674 http://dx.doi.org/10.1186/s13321-016-0121-y |
work_keys_str_mv | AT montanarifloriane selectivityprofilingofbcrpversuspgpinhibitionfromautomatedcollectionofpolypharmacologydatatomultilabellearning AT zdrazilbarbara selectivityprofilingofbcrpversuspgpinhibitionfromautomatedcollectionofpolypharmacologydatatomultilabellearning AT diglesdaniela selectivityprofilingofbcrpversuspgpinhibitionfromautomatedcollectionofpolypharmacologydatatomultilabellearning AT eckergerhardf selectivityprofilingofbcrpversuspgpinhibitionfromautomatedcollectionofpolypharmacologydatatomultilabellearning |